Oleg S. Selawry

4.5k total citations · 1 hit paper
46 papers, 3.3k citations indexed

About

Oleg S. Selawry is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Oleg S. Selawry has authored 46 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Oleg S. Selawry's work include Lung Cancer Research Studies (10 papers), Lung Cancer Treatments and Mutations (9 papers) and Acute Lymphoblastic Leukemia research (7 papers). Oleg S. Selawry is often cited by papers focused on Lung Cancer Research Studies (10 papers), Lung Cancer Treatments and Mutations (9 papers) and Acute Lymphoblastic Leukemia research (7 papers). Oleg S. Selawry collaborates with scholars based in United States, South Africa and Austria. Oleg S. Selawry's co-authors include Franco M. Muggia, Patrick J. Creaven, H.H. Hansen, Emil Frei, Heine H. Hansen, Maurice Cohen, Lawrence E. Broder, Martin H. Cohen, Clyde O. Brindley and Bruce I. Shnider and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Oleg S. Selawry

44 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide

1960 865 citations C. Gordon Zubrod, Marvin A. Schneiderman et al. Journal of Chronic Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Oleg S. Selawry United States	24	1.5k	903	731	524	482	46	3.3k
Raymond B. Weiss United States	31	2.1k 1.4×	786 0.9×	584 0.8×	409 0.8×	269 0.6×	84	3.7k
Charlotte Tan United States	28	836 0.5×	535 0.6×	580 0.8×	242 0.5×	704 1.5×	66	3.0k
R L Souhami United Kingdom	29	1.4k 0.9×	983 1.1×	531 0.7×	583 1.1×	282 0.6×	84	2.6k
W M Hryniuk Canada	22	1.9k 1.2×	570 0.6×	386 0.5×	275 0.5×	255 0.5×	32	3.2k
Walter G. Gunn United States	17	1.9k 1.2×	1.4k 1.6×	806 1.1×	454 0.9×	207 0.4×	45	4.5k
R L Souhami United Kingdom	25	1.3k 0.8×	1.5k 1.7×	529 0.7×	333 0.6×	264 0.5×	53	3.0k
R. M. Fox Australia	29	2.1k 1.4×	581 0.6×	957 1.3×	379 0.7×	424 0.9×	77	4.8k
Edward S. Henderson United States	30	2.0k 1.3×	727 0.8×	522 0.7×	421 0.8×	769 1.6×	98	4.8k
Robert L. Comis United States	41	3.4k 2.2×	2.1k 2.3×	1.3k 1.8×	1.1k 2.2×	454 0.9×	137	5.6k
Jeffrey Tobias United Kingdom	34	1.6k 1.0×	1.0k 1.1×	416 0.6×	549 1.0×	379 0.8×	136	3.7k

Countries citing papers authored by Oleg S. Selawry

Since Specialization

Citations

This map shows the geographic impact of Oleg S. Selawry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oleg S. Selawry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oleg S. Selawry more than expected).

Fields of papers citing papers by Oleg S. Selawry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oleg S. Selawry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oleg S. Selawry. The network helps show where Oleg S. Selawry may publish in the future.

Co-authorship network of co-authors of Oleg S. Selawry

This figure shows the co-authorship network connecting the top 25 collaborators of Oleg S. Selawry. A scholar is included among the top collaborators of Oleg S. Selawry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oleg S. Selawry. Oleg S. Selawry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Broder, Lawrence E., et al.. (1994). A Randomized Clinical Trial in Bronchogenic Small-Cell Carcinoma Evaluating Alternating Maintenance Therapy of Vincristine, Adriamycin, Procarbazine, and Etoposide (VAPE) with Cyclophosphamide, CCNU, and Methotrexate (CCM) versus CCM Maintenance Alone in Complete Responders Following VAPE Induction and Late Intensification. American Journal of Clinical Oncology. 17(6). 527–537. 8 indexed citations

Selawry, Oleg S., et al.. (1992). The impact of surgery on the multidisciplinary treatment of bronchogenic small cell carcinoma. Medical Oncology and Tumor Pharmacotherapy. 9(3). 119–137. 4 indexed citations

Tisi, Gennaro M., Paul J. Friedman, Richard M. Peters, et al.. (1983). Clinical Staging of Primary Lung Cancer. American Review of Respiratory Disease. 127(5). 659–664. 229 indexed citations

Broder, Lawrence E., Martin H. Cohen, & Oleg S. Selawry. (1977). Treatment of bronchogenic carcinoma. Cancer Treatment Reviews. 4(4). 219–260. 88 indexed citations

Cohen, Martin H., Patrick J. Creaven, Byron E. Fossieck, et al.. (1977). Intensive chemotherapy of small cell bronchogenic carcinoma.. PubMed. 61(3). 349–54. 212 indexed citations

Selawry, Oleg S., et al.. (1977). Phase I clinical trials.. PubMed. 75–80. 101 indexed citations

Edmonson, J H, Stephen W. Lagakos, Oleg S. Selawry, et al.. (1976). Cyclophosphamide and CCNU in the treatment of inoperable small cell carcinoma and adenocarcinoma of the lung.. PubMed. 60(7). 925–32. 57 indexed citations

Hansen, Heine H., et al.. (1976). Combination chemotherapy of advanced lung cancer.A randomized trial. Cancer. 38(6). 2201–2207. 67 indexed citations

Smith, James C., et al.. (1973). Serum Zinc Concentration: An Unreliable Parameter for Diagnosing Bronchogenic Carcinoma. JNCI Journal of the National Cancer Institute. 51(4). 1379–1381. 1 indexed citations

10.

Muggia, Franco M., Patrick J. Creaven, H.H. Hansen, Maurice Cohen, & Oleg S. Selawry. (1972). Phase I clinical trial of weekly and daily treatment with camptothecin (NSC-100880): correlation with preclinical studies.. PubMed. 56(4). 515–21. 275 indexed citations

11.

Hansen, Heine H., Franco M. Muggia, Robert J. Andrews, & Oleg S. Selawry. (1972). Intensive combined chemotherapy and radiotherapy in patients with nonresectable bronchogenic carcinoma. Cancer. 30(2). 315–324. 42 indexed citations

12.

Ennis, Herbert L., et al.. (1971). 2,3-Dihydro-1H-imidazo[1,2-b]pyrazole. Biochemical Pharmacology. 20(10). 2639–2646. 22 indexed citations

13.

Carbone, Paul P., Charles M. Haskell, Brigid G. Leventhal, Jerome B. Block, & Oleg S. Selawry. (1970). Clinical Experience with L-Asparaginase. Recent results in cancer research. 33. 236–243. 10 indexed citations

14.

Selawry, Oleg S., et al.. (1966). Cholesteric thermography in tumors of the head and neck. The American Journal of Surgery. 112(4). 537–540. 3 indexed citations

15.

Freireich, Emil J., Edmund A. Gehan, Emil Frei, et al.. (1963). The Effect of 6-Mercaptopurine on the Duration of Steroid-induced Remissions in Acute Leukemia: A Model for Evaluation of Other Potentially Useful Therapy. Blood. 21(6). 699–716. 166 indexed citations

16.

SCHROEDER, LESLIE R., et al.. (1962). Morphological classification of acute leukemias.. PubMed. 16. 151–3. 5 indexed citations

17.

Mihich, Enrico, et al.. (1962). Hypoglycemic effects of methylglyoxal bis (guanylhydrazone) in animals and man.. PubMed. 16. 177–81. 6 indexed citations

18.

Holland, James F., Edmund A. Gehan, Clyde O. Brindley, et al.. (1961). A comparative study of optimal medical care with and without azaserine in multiple myeloma. Clinical Pharmacology & Therapeutics. 2(1). 22–28. 12 indexed citations

19.

Zubrod, C. Gordon, Marvin A. Schneiderman, Emil Frei, et al.. (1960). Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. Journal of Chronic Diseases. 11(1). 7–33. 865 indexed citations breakdown →

20.

Gold, G. Lennard, Thomas C. Hall, Oleg S. Selawry, et al.. (1959). A clinical study of 5-fluorouracil.. PubMed. 19. 935–9. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact